Surgical Science Sweden AB (publ) (STO:SUS)

STO:SUS Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	658.39	616.43	968.16	634.37	433.73	316.68
Cash & Short-Term Investments	658.39	616.43	968.16	634.37	433.73	316.68
Cash Growth	7.89%	-36.33%	52.62%	46.26%	36.96%	263.34%
Accounts Receivable	126.53	136.98	136.7	110.6	176.31	110.65
Other Receivables	83.22	205.57	121.44	81.11	67.81	69.14
Receivables	209.75	342.54	258.14	191.71	244.13	179.79
Inventory	234.16	205.97	179.58	154.45	134.88	113.11
Prepaid Expenses	157.79	19.74	20.13	10.67	13.63	7.33
Other Current Assets	-	-	0	-	-	-
Total Current Assets	1,260	1,185	1,426	991.19	826.37	616.91
Property, Plant & Equipment	118.62	106.35	101.53	76.62	51.36	38.39
Goodwill	3,241	3,077	3,616	3,329	3,444	3,019
Other Intangible Assets	321.89	300.9	311.91	286.57	301.02	274.03
Long-Term Deferred Tax Assets	16.89	13.58	16.33	14.84	22.16	24.6
Other Long-Term Assets	12.15	8.62	8.05	4.77	4.37	4.97
Total Assets	4,971	4,691	5,480	4,703	4,650	3,978

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	36.25	58.45	41.29	65.69	34.37
Accrued Expenses	-	86.31	58.12	47.34	44.27	104.18
Current Income Taxes Payable	-	49.66	51.44	31.03	13.9	5.49
Current Unearned Revenue	-	66.67	66.83	72.89	70.65	16.95
Other Current Liabilities	297.02	53.87	277.89	42.39	111.4	71.39
Total Current Liabilities	297.02	292.76	512.72	234.94	305.91	232.38
Long-Term Leases	-	56.4	56.94	40.02	14.68	12.07
Long-Term Unearned Revenue	-	15.27	19.47	20.29	27.62	20.49
Long-Term Deferred Tax Liabilities	-	33.45	43.55	45	51.51	48.51
Other Long-Term Liabilities	120.14	20.44	18.36	17.21	13.4	79.61
Total Liabilities	420.02	418.31	651.03	357.46	413.11	393.06

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.55	2.55	2.55	2.55	2.54	2.54
Additional Paid-In Capital	3,398	3,398	3,398	3,398	3,379	3,379
Retained Earnings	745.7	706.23	639.41	507.76	273.79	85.82
Comprehensive Income & Other	404.49	166.16	788.56	436.78	581.14	117.73
Shareholders' Equity	4,551	4,273	4,829	4,345	4,236	3,585
Total Liabilities & Equity	4,971	4,691	5,480	4,703	4,650	3,978

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.86	56.4	56.94	40.02	14.68	12.07
Net Cash (Debt)	655.53	560.03	911.22	594.34	419.05	304.61
Net Cash Growth	7.72%	-38.54%	53.31%	41.83%	37.57%	259.05%
Net Cash Per Share	12.85	10.98	17.86	11.67	8.23	7.14
Filing Date Shares Outstanding	51.03	51.03	51.03	51.03	50.8	50.8
Total Common Shares Outstanding	51.03	51.03	51.03	51.03	50.8	50.8
Working Capital	963.07	891.92	913.29	756.26	520.46	384.53
Book Value Per Share	89.19	83.74	94.63	85.16	83.39	70.57
Tangible Book Value	987.72	894.92	900.89	729.96	491.14	291.81
Tangible Book Value Per Share	19.36	17.54	17.66	14.31	9.67	5.74
Machinery	-	276.64	186.66	132.67	91.23	58.54

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error